What are the responsibilities and job description for the Senior Medical Science Liaison position at Sarepta Therapeutics, Inc.?
Why Sarepta? Why Now? The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, central nervous system, and cardiac diseases. In 2023, we launched our fourth therapy and the first ever gene therapy to treat Duchenne. We’re looking for people who see unlimited potential in themselves and who are motivated by an unwavering commitment to patients. What Sarepta Offers At Sarepta, we care deeply about all the people in our community and believe in the importance of supporting them in all aspects of their lives. We aspire to maintain a culture that acknowledges people bring their whole selves to work, and we will strive to help everyone in our community integrate their work and personal lives while maintaining productivity. We are committed to offering a range of benefits and work-life resources designed to support people in the following areas: Physical and Emotional Wellness Financial Wellness Support for Caregivers For a full list of our comprehensive benefits, see our website: https://www.sarepta.com/join-us The Importance of the Role The Sr. MSL will play a pivotal role in the education of healthcare professionals (HCPs) about Duchenne Muscular Dystrophy as well as Sarepta’s investigational therapeutics and product pipeline. Reporting to the Region Team Leader, the Sr. MSL position will play a pivotal role in the education of healthcare professionals (HCPs) about Duchenne Muscular Dystrophy as well as Sarepta’s investigational therapeutics and product pipeline. The incumbent is expected to have expertise in the field of Neurology / Pediatrics and to be a scientific expert regarding Sarepta’s portfolio of products. MSL will serve as a resource for scientific information for key customers, including but not limited to national and regional opinion leaders, investigators, advisors, and physician networks. The successful candidate will be highly driven individual who combines scientific knowledge with a focus on customer service and compassion for the patients we serve. The person in this position will also need to be willing to actively contribute to the establishment of MSL process and policy, KOL strategy development, and tactical planning. The Opportunity to Make a Difference Identify, establish, and maintain collaborative relationships with key opinion leaders, investigators, and institutions within academic, clinical, and health care organizations in a defined territory Implement KOL field strategy, KOL identification, speaker development, and support Leadership role in medical education for healthcare professionals through proactive communication of scientific data as well as scientific exchange of information during routine interactions High quality presentations of scientific data to health care professionals in various settings, including advisory boards, investigator meetings, and other appropriate venues to enhance product / disease state knowledge Provide on-site support to clinical operations for investigators in ongoing clinical trials, investigator-initiated studies, and registries consistent with company objectives and regulations Visit potential sites to assess their capabilities with regard to conduct these various forms of clinical research Provide professional medical affairs representation and support at global, national and regional scientific meetings, including but not limited to staffing medical affairs booths, gathering competitive intelligence, and partnering with medical information to develop post-conference scientific materials Develop and maintain clinical expertise in Duchenne muscular dystrophy through review of scientific journals, recent data disclosures and participation in scientific congresses Demonstrate an understanding of key medical and commercial strategies and provide medical support for commercial activities. More about You MD, PhD, PharmD, or NP/PA preferred 5 years of MSL experience a plus Familiarity with and track record of complying with industry and regulatory compliance guidelines Demonstrated ability to work independently and in collaborative team environment Existing Neurology / Pediatric experience and relationships is a plus, experience in immunology and/or gene therapy a plus. Willingness to travel >50% of time Experience and expertise in clinical trial design, interpretation of scientific data, competitive intelligence tools, drug information systems, and medical marketing strategies High integrity, sense of urgency, ability to recognize time sensitivity Excellent written and verbal communication skills, exceptional listening skills, strong presentation skills, and good negotiating and influencing skills What Now? We’re always looking for solution-oriented, critical thinkers. So, if you’re comfortable with ambiguity and candor, relish challenging yourself, and place kindness and integrity at the forefront of how you approach your peers and work, then we encourage you to apply. #LI-Hybrid #LI-CM1 This position is hybrid, you will be expected to work on site at one of Sarepta’s facilities in the United States and/or attend Company-sponsored in-person events from time to time. The targeted salary range for this position is $0 - $0 per year. Sarepta is making a good faith effort to be transparent and accurate around our hiring ranges. The salary offer is commensurate with Sarepta’s compensation philosophy and considers factors including, but not limited to, education, training, experience, external market conditions, criticality of role, and internal equity. Candidates must be authorized to work in the U.S. Sarepta Therapeutics offers a competitive compensation and benefit package. Sarepta Therapeutics is an Equal Opportunity/Affirmative Action employer and participates in e-Verify. Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, central nervous system, and cardiac diseases. Our deep pipeline is driven by our multi-platform technologies in siRNA, RNA and gene therapy. For more information, please visit www.sarepta.com or follow us on Twitter, LinkedIn, Instagram and Facebook.